Grosfeld J L, West K W, Weber T R
Am J Pediatr Hematol Oncol. 1984 Winter;6(4):441-7. doi: 10.1097/00043426-198424000-00009.
Forty-two infants and children with retroperitoneal solid tumors underwent second operative procedures. Twenty-three children had stage III (4) or stage IV (19) neuroblastoma and 19 had Wilms' tumor. This report suggests that second-look procedures are quite beneficial in selected cases. In children with Wilms' tumor, second procedures are most useful in those patients inadequately staged with flank operations, in cases of bilateral tumors, and in children with initially unresectable tumors following cytoreduction. Patients with significant tumor spill at a previous procedure may also benefit from early reoperation. Late recurrence of tumor, especially in children with unfavorable histology and/or hematogenous liver metastases, carries an ominous prognosis. Ten of the 19 patients with Wilms' tumor are long-term survivors (52.6%). Patients with initially unresectable (stage III) neuroblastoma occurring in the pelvis respond well to second-look resection. Children with primary tumors surrounding the celiac axis eventually died despite subsequent resection. Although the efficacy of primary tumor resection in cases of metastatic neuroblastoma remains controversial, stage IV patients with tumor resection had a longer duration of survival. Our only long-term survivors had their primary tumors resected. Second-look or delayed abdominal operations in metastatic cases may be useful in assessing the effectiveness of treatment and for sampling of retroperitoneal lymph nodes as a prognostic indicator.
42例患有腹膜后实体瘤的婴幼儿和儿童接受了二次手术。23例儿童患有III期(4例)或IV期(19例)神经母细胞瘤,19例患有肾母细胞瘤。本报告表明,二次探查手术在某些特定病例中相当有益。对于肾母细胞瘤患儿,二次手术在那些经侧腹手术分期不充分的患者、双侧肿瘤病例以及初次减瘤后最初无法切除肿瘤的患儿中最为有用。在前一次手术中有明显肿瘤溢出的患者也可能从早期再次手术中获益。肿瘤的晚期复发,尤其是组织学不良和/或有血行性肝转移的患儿,预后不佳。19例肾母细胞瘤患者中有10例是长期幸存者(52.6%)。最初无法切除(III期)的盆腔神经母细胞瘤患者对二次探查切除反应良好。围绕腹腔动脉轴的原发性肿瘤患儿尽管随后进行了切除,但最终还是死亡。虽然转移性神经母细胞瘤病例中原发性肿瘤切除的疗效仍存在争议,但接受肿瘤切除的IV期患者生存期更长。我们仅有的长期幸存者都接受了原发性肿瘤切除。转移性病例中的二次探查或延迟腹部手术可能有助于评估治疗效果以及对腹膜后淋巴结进行取样作为预后指标。